Learn more about the latest clinical microbiology issues and trends from those who know it best
Explore our Clinical Webinar Library to learn about the latest issues and trends within clinical microbiology, and discover advances in blood culture, susceptibility testing
Watch webinars from experts working in the fields of
Microbiology and stewardship: Understanding AST data as a driver of antimicrobial stewardship
Speaker: Professor Romney Humphries, Medical Director of the Microbiology Laboratory, Vanderbilt University Medical Center
Learn how antimicrobial susceptibility testing (AST) data may influence the optimal use of antibiotics and better guide and support your stewardship programs.
Topics include:
Identifying core elements of microbiology lab testing and reporting that promote stewardship
Understanding minimum inhibitory concentration (MIC)-driven therapeutic decisions
Describing antimicrobial therapy challenges in critically ill patients
Related Thermo Scientific™ products:
Multidrug-resistant organisms: Improving time to effective treatment
Speaker: Dr. Jose Alexander, Director, Clinical Microbiologist at AdventHealth Orlando
Topics include:
- The impact of beta-lactamase on the effectiveness of existing and new antibiotics?
- What phenotypic tools can be used to predict evolving resistance?
- The impact on patient outcomes and the true cost of therapy (length of stay (LOS), duration of therapy (DOT), antibiotic (ABX) days) when prescribing ineffective treatment?
Antimicrobial Stewardship – Exploring the Pharmacy/Microbiology Laboratory Partnership
Speaker: Dr. Jerod Nagel, PharmD, BCPS (AQID)
Topics include:
- How Antimicrobial Stewardship Programs reduce the risk of inappropriate antimicrobial usage, which can help optimize patient outcomes, as well as reduce costs.
- How the microbiology lab can team up with the pharmacy on AST results that promote antibiotic de-escalation and aid clinical decision-making.
Selective Reporting - How the Microbiology Lab Can Optimize Patient Outcomes
Speaker: Romney M. Humphries,
Topics include:
- How selectively reporting on the susceptibilities of broad-spectrum agents can de-escalate antibiotic usage and positively impact clinical decision-making
- Strategies for selective/cascade reporting
- Evaluating the impact of selective reporting
Harnessing Microbiology Laboratory Data: Practical Tips for Antimicrobial Stewardship
Speaker: Romney M. Humphries,
Topics include:
- How the essential reporting of changing sensitivity patterns influences the optimal use of antibiotics
- The pivotal role microbiology labs play in successful antimicrobial stewardship programs
Q&A on Clinical Lab Strategies for Combating Antimicrobial Resistance
Speaker: Romney M. Humphries,
Topics include:
- Common questions on implementation, testing and reporting to support the prevention of antimicrobial resistance
- Guiding antimicrobial stewardship programs and driving improved patient outcomes
Confronting Antibiotic Resistance: Clinical Laboratory Perspective
Discovery Day Location: San Mateo, CA
Speaker: Romney M. Humphries, PhD D(ABMM). Section Chief, Clinical Microbiology at UCLA Health.
Topics include:
- Case studies related to sepsis, antimicrobial resistance and epidemiological implications
- Overview of current technologies and new antimicrobials
Keeping Up with the Candidas: New Guidelines and Troublesome MICs
Discovery Day Location: San Mateo, CA
Speaker: Jon Faldasz, PharmD BCPS. Infectious Disease Specialist at UCSF Mission Bay
Topics include:
- Changes to Candida testing guidelines and how they impact laboratory practice
- Meaning and implications of S-DD
- Utility of echinocandin susceptibility testing
- Application of Candida antifungal MICs to
clinical isolates
Challenging Bacterial Infections – The Clinical Impact of Critical Microbiology Results
Speaker: James A. McKinnell, MD, Assistant Professor of Medicine, David Geffen School of Medicine, University of California, Los Angeles; Division of Infectious Disease, LA-Biomed at Harbor UCLA Medical Center
Topics include:
- How to steer antibiotic treatment choices that are critical to patient care, including reliable detection of existing and emerging resistance to new drugs, as well as antimicrobials of last resort.
- Results from microbiology laboratories that can potentially impact patient care.
Antimicrobial Stewardship and the Role of Thermo Scientific™ Sensititre™
Discovery Day Location: Charlotte, NC
Speaker: Jerod Nagel, PharmD, BCPS (AQID), Clinical Pharmacist, Infectious Diseases. Clinical Assistant Professor, Director Infectious Diseases Residency at the University of Michigan Health System.
Topics include:
- The antimicrobial stewardship movement, program goals and the role of the microbiology lab
- Priorities in selecting automated systems
and reporting - Other considerations for antimicrobial susceptibility testing (AST)
The Diagnostic Challenges of Mycobacterial Infections
Speaker: Nathan A. Ledeboer, PhD, D(ABMM), Associate Professor of Pathology, Medical Director, Clinical Microbiology and Medical Director, Molecular Diagnostics at Medical College of Wisconsin; Senior Editor, Journal of Clinical Microbiology
Topics include:
- Recovery of Mycobacterium from a suspected infection and the critical role of susceptibility testing for guiding therapy
- Diagnostic challenges of Mycobacterium, including low bacterial load and small sample size associated with non-pulmonary infections, and the long time requirements for incubation
- Current and evolving technologies available to microbiology laboratories in the identification and susceptibility testing of mycobacterial infections
Verification of Antimicrobial Susceptibility Tests
Speaker: Romney Humphries, PhD D(ABMM). Section Chief, Clinical Microbiology at UCLA Health
Thermo Scientific™ Sensititre™ System – Bringing new drugs onto an existing system or verifying a new system.
Topics include:
- Criteria, definitions and acceptable limits for accuracy and precision testing
- Isolates for verification studies
- Sample verification plans
The Race Is On: Faster Turnaround Times in the Diagnosis of Multidrug-Resistant Tuberculosis
Speaker: Max Salfinger, M.D., National Jewish Health
Topics include:
- The changing epidemiology of drug-resistant TB in the United States and globally, as well as the various molecular laboratory assays used to diagnose TB.
Antimicrobial Susceptibility Testing (AST) Solutions
Satisfy your antimicrobial susceptibility testing (AST) requirements with high performance automated and manual test products to help ensure patients are on the most appropriate treatment plan.
